Abstract
Endocannabinoids are endogenous lipid mediators recognized by the cannabinoid-1 and 2 (CB1 and CB2, respectively) receptors that mediate the effects of marijuana. The endocannabinoid system, consisting of endocannabinoids (eCBs), their receptors, and the enzymes involved in their biosynthesis and degradation, is present in many tissues including the liver. The present chapter reviews accumulating evidence that the eCB system is involved in the regulation of de novo hepatic lipogenesis.
| Original language | English |
|---|---|
| Title of host publication | Hepatic De Novo Lipogenesis and Regulation of Metabolism |
| Publisher | Springer International Publishing |
| Pages | 131-142 |
| Number of pages | 12 |
| ISBN (Electronic) | 9783319250656 |
| ISBN (Print) | 9783319250632 |
| DOIs | |
| State | Published - 1 Jan 2015 |
Bibliographical note
Publisher Copyright:© Springer International Publishing Switzerland 2016.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- CB receptor
- CB receptor
- Diet-induced obesity
- Endocannabinoids
- Fatty liver
- Hepatic lipogenesis
- Monounsaturated fatty acids
Fingerprint
Dive into the research topics of 'Role of the endocannabinoid system in hepatic lipogenesis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver